D'Ugo, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 7.817
AS - Asia 6.492
EU - Europa 5.382
SA - Sud America 1.233
Continente sconosciuto - Info sul continente non disponibili 410
AF - Africa 191
OC - Oceania 14
Totale 21.539
Nazione #
US - Stati Uniti d'America 7.560
SG - Singapore 3.000
DE - Germania 1.386
CN - Cina 1.378
BR - Brasile 1.015
IT - Italia 891
SE - Svezia 766
VN - Vietnam 564
FR - Francia 529
NL - Olanda 421
IN - India 323
UA - Ucraina 308
GB - Regno Unito 285
IE - Irlanda 235
BD - Bangladesh 223
JP - Giappone 204
ID - Indonesia 173
CA - Canada 133
HK - Hong Kong 133
TR - Turchia 119
RU - Federazione Russa 117
FI - Finlandia 104
AR - Argentina 95
IQ - Iraq 74
MX - Messico 70
PL - Polonia 68
ES - Italia 64
KR - Corea 61
ZA - Sudafrica 48
AT - Austria 44
BE - Belgio 35
EC - Ecuador 29
SA - Arabia Saudita 27
CI - Costa d'Avorio 26
MA - Marocco 26
PK - Pakistan 25
VE - Venezuela 25
CL - Cile 18
CZ - Repubblica Ceca 18
LT - Lituania 18
UZ - Uzbekistan 16
CO - Colombia 15
IL - Israele 15
JO - Giordania 15
KE - Kenya 15
PE - Perù 15
ET - Etiopia 14
AE - Emirati Arabi Uniti 13
AZ - Azerbaigian 13
IR - Iran 13
PH - Filippine 13
RO - Romania 13
TN - Tunisia 13
EG - Egitto 12
MY - Malesia 12
CH - Svizzera 11
GR - Grecia 11
PS - Palestinian Territory 11
NP - Nepal 10
AU - Australia 9
DZ - Algeria 9
TH - Thailandia 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
HN - Honduras 8
LB - Libano 8
PY - Paraguay 8
BO - Bolivia 7
JM - Giamaica 7
KG - Kirghizistan 7
SN - Senegal 7
AL - Albania 6
LV - Lettonia 6
MD - Moldavia 6
PA - Panama 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
CR - Costa Rica 5
EE - Estonia 5
OM - Oman 5
UY - Uruguay 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
CY - Cipro 4
EU - Europa 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BB - Barbados 3
BH - Bahrain 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
RS - Serbia 3
VG - Isole Vergini Britanniche 3
CG - Congo 2
KW - Kuwait 2
LU - Lussemburgo 2
Totale 21.101
Città #
Singapore 1.600
Chandler 1.049
San Jose 876
Ashburn 748
Amsterdam 377
Beijing 294
Dublin 232
Los Angeles 230
New York 212
Ho Chi Minh City 202
Tokyo 196
San Mateo 188
Lauterbourg 183
Hefei 182
Jacksonville 173
Milan 159
Wilmington 154
Jakarta 149
Rome 148
Hanoi 139
Hong Kong 128
Hyderabad 123
Nanjing 118
Ann Arbor 100
Frankfurt am Main 98
São Paulo 95
Princeton 91
Chicago 85
Munich 79
Nürnberg 78
Santa Clara 73
Houston 70
Moscow 68
Dallas 66
Boston 65
Izmir 65
Cattolica 64
Dearborn 63
The Dalles 59
Buffalo 58
Marseille 58
Woodbridge 57
Seoul 56
Boardman 51
Warsaw 48
Fairfield 47
Brooklyn 45
Kent 45
Verona 44
Atlanta 43
Lancaster 41
Nuremberg 41
Zhengzhou 41
Lawrence 39
Montreal 39
Seattle 39
London 37
Nanchang 36
Bremen 35
Toronto 35
Brussels 34
Orem 34
Redwood City 34
Helsinki 33
Chennai 32
Council Bluffs 32
Denver 32
Norwalk 32
Paris 32
Rio de Janeiro 32
Mountain View 31
Johannesburg 30
Baghdad 29
San Francisco 29
Shenyang 27
Stockholm 27
Abidjan 26
Shanghai 26
Curitiba 25
Da Nang 25
Phoenix 25
Tianjin 24
Düsseldorf 23
Manchester 23
Poplar 22
Belo Horizonte 21
Haiphong 21
St Louis 21
Changsha 20
Brasília 19
Dhaka 19
Hebei 19
Vienna 19
Campinas 18
Mexico City 18
Cambridge 17
Augusta 16
Kunming 15
Leawood 15
Mumbai 15
Totale 11.006
Nome #
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 539
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 436
NutriCatt protocol in the enhanced recovery after surgery (ERAS) program for colorectal surgery: the nutritional support improves clinical and cost-effectiveness outcomes. 259
The Road to Curative Surgery in Gastric Cancer Treatment: A Different Path in the Elderly? 249
A case-control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progression 247
Feasibility of discharge within 72 hours of major colorectal surgery: lessons learned after 5 years of institutional experience with the ERAS protocol 230
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 229
Surgery in COVID-19 patients: Operational directives 229
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 220
Susceptibility to Helicobacter pylori infection: results of an epidemiological investigation among gastric cancer patients 206
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 193
Perioperative chemotherapy for gastric cancer: how should we measure the efficacy? 189
cDNA-Microarray Analysis as a New Tool to Predict Lymph Node Metastasis in Gastric Cancer 187
Transanal Total Mesorectal Excision vs Laparoscopic Total Mesolectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis. 186
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 182
Education and imaging: gastrointestinal: videocapsule retention: rationale for surgical indication 180
Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer 176
Acute pancreatitis associated with primary hyperparathyroidism 175
Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives 172
R0 resection in the treatment of gastric cancer: room for improvement 170
Log odds of positive lymph nodes in colon cancer: a meaningful ratio-based lymph node classification system 169
Metastatic lymph node ratio: a new staging system for gastric cancer 167
3D pelvimetry and biometric measurements: a surgical perspective for colorectal resections 165
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 162
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 161
Harlequin Syndrome 161
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer 160
Therapeutic implications of mesenchymal stem cells in liver injury 159
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 158
Large bowel auto-amputation and passage of a colon 'cast' after left hemicolectomy 157
Determinants of surgical morbidity in gastric cancer treatment 157
The gut microbiota and colorectal surgery outcomes: facts or hype? A narrative review 157
The learning curve of TaTME for mid-low rectal cancer: a comprehensive analysis from a five-year institutional experience 157
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 155
Preoperative treatment and surgery in gastric cancer: friends or foes? 149
Impact of the COVID-19 Pandemic on Enhanced Recovery After Surgery (ERAS) Application and Outcomes: Analysis in the “Lazio Network” Database 148
Prognostic Value of Preoperative Staging in Gastric Cancer 144
Enhanced recovery after surgery (ERAS) program in octogenarian patients: a propensity score matching analysis on the "Lazio Network" database 142
Prognostic value of preoperative staging in gastric cancer 142
Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery 142
D1-plus vs D2 nodal dissection in gastric cancer: A propensity score matched comparison and review of published literature 142
Association between colorectal cancer and streptococcus gallolyticus subsp. pasteuranus (former s. bovis) endocarditis: Clinical relevance and cues for microbiota science. case report and review of the literature 141
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 139
Tumor size as a prognostic factor in patients with stage IIa colon cancer 138
Preoperative therapy and long-term survival in gastric cancer: One size does not fit all 138
Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study 138
Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy 137
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 135
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer 135
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 133
The prognostic role of perioperative allogeneic blood transfusions in gastric cancer patients undergoing curative resection: A systematic review and meta-analysis of non-randomized, adjusted studies 133
Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy 132
REGATTA trial: a call for the USA and Europe 132
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 131
Preoperative chemotherapy in gastric cancer: expanding the indications, limiting the overuse 131
The "Lazio Network" experience. The first Italian regional research group on the Enhanced Recovery After Surgery (ERAS) program. A collective database with 1200 patients in 2016-2017 131
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 131
Nutricatt protocol improves body composition and clinical outcomes in elderly patients undergoing colorectal surgery in eras program: A retrospective cohort study 131
Follow-Up After Gastrectomy for Cancer: An Appraisal of the Italian Research Group for Gastric Cancer 129
Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? 129
Giant inflammatory polyposis as the first manifestation of inflammatory bowel disease 128
Clostridium difficile infection after stoma reversal surgery: a systematic review and meta-analysis of the literature 126
The role of local excision in rectal cancer after complete response to neoadjuvant treatment 126
Towards the goal of r0 resection in locally advanced gastriccancer through the path of neoadjuvant chemotherapy e impact of tumour downstaging on survival in a single series. 122
Intraoperative esophageal manometry in surgical treatment of achalasia: a reappraisal. 122
The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer 122
Gastric cancer: Current status of lymph node dissection 122
Beyond the Guidelines: The Grey Zones of the Management ofGastric Cancer. Consensus Statements from the Gastric CancerItalian Network (GAIN) 119
Quality Over Volume: Modeling Centralization of Gastric Cancer Resections in Italy 118
Pseudoaneurysms after curative-aim gastrectomy for gastric carcinoma: clinical presentation and management 117
Imagine a world without cancer 117
Preoperative chemotherapy in gastric cancer: expanding the indications, limiting the overuse 117
Surgical issues after neoadjuvant treatment for gastric cancer 116
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 116
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 116
Italian multi-society modified Delphi consensus on the definition and management of anastomotic leakage in colorectal surgery 116
Updates on surgical management of advanced gastric cancer: new evidence and trends. Insights from the First International Course on Upper Gastrointestinal Surgery--Varese (Italy), December 2, 2011 115
Transesophageal echocardiographic assessment of hemodynamic function during laparoscopic cholecystectomy in healthy patients. 115
Follow-up: the evidence 113
Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database 112
Minimally invasive vs. open segmental resection of the splenic flexure for cancer: a nationwide study of the Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CNN) 112
Limited lymph node dissection and metastatic lymph node ratio: a wave of trust 112
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 112
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 112
Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomies. 110
Image of the month--quiz case. 108
The scintigraphic prediction of residual lung function after lobectomy in patients with bronchial carcinoma 108
Krukenberg tumors: Seed, route and soil 107
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis 107
Four steps in the evolution of rectal cancer managements through 40 years of clinical practice: Pioneering, standardization, challenges and personalization 106
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) 105
Thyroid cancer in suppressed contralateral lobe of patients with hot thyroid nodule 105
Global updates in the treatment of gastric cancer: a systematic review. Part 1: staging, classification and surgical treatment 105
Impact of Diagnostic laparoscopy on the managment of gastic cancer: prospective study of 120 consecutive patients with primary gastric adenocarcinoma 104
Profiling complete regression after pre-operative therapy in gastric cancer patients using clinical and pathological data 103
Log odds of positive lymph nodes in colon cancer: a meaningful ratio-based lymph node classification system 103
The Use of Indocyanine Green (ICG) and Near-Infrared (NIR) Fluorescence-Guided Imaging in Gastric Cancer Surgery: A Narrative Review 103
Synchronous gastric adenocarcinoma and MALT lymphoma in a patient with H. pylori infection. Could the two neoplasms share a common pathogenesis? 103
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 103
Fashioning enterotomy closure after totally laparoscopic ileocolic anastomosis for right colon cancer: a multicenter experience 101
Totale 14.956
Categoria #
all - tutte 91.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022960 0 62 18 129 37 16 16 195 35 63 193 196
2022/20232.576 339 339 193 421 157 320 104 194 351 27 97 34
2023/20241.189 58 337 34 62 44 135 71 22 18 81 140 187
2024/20253.535 50 73 245 196 339 105 121 143 474 411 820 558
2025/20269.072 1.357 253 536 946 1.542 772 1.444 415 646 559 364 238
2026/2027576 315 261 0 0 0 0 0 0 0 0 0 0
Totale 21.539